Works matching IS 13479032 AND DT 2022 AND VI 113 AND IP 11


Results: 36
    1

    Correction.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 4011, doi. 10.1111/cas.15535
    Publication type:
    Article
    2
    3
    4
    5
    6

    Correction.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 4013, doi. 10.1111/cas.15588
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3912, doi. 10.1111/cas.15539
    By:
    • Otsuka, Hikari;
    • Kita, Yuki;
    • Ito, Katsuhiro;
    • Sano, Takeshi;
    • Inokuchi, Junichi;
    • Tomida, Ryotaro;
    • Takahashi, Atsushi;
    • Matsumoto, Kazumasa;
    • Kurahashi, Ryoma;
    • Ozaki, Yu;
    • Uegaki, Masayuki;
    • Maruyama, Satoru;
    • Mukai, Shoichiro;
    • Tsutsumi, Masakazu;
    • Kawahara, Takashi;
    • Segawa, Takehiko;
    • Kitamura, Hiroshi;
    • Morita, Satoshi;
    • Kobayashi, Takashi
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22

    In this issue.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3643, doi. 10.1111/cas.14964
    Publication type:
    Article
    23
    24
    25
    26
    27

    Chronological improvement in precision oncology implementation in Japan.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3995, doi. 10.1111/cas.15517
    By:
    • Sunami, Kuniko;
    • Naito, Yoichi;
    • Komine, Keigo;
    • Amano, Toraji;
    • Ennishi, Daisuke;
    • Imai, Mitsuho;
    • Kage, Hidenori;
    • Kanai, Masashi;
    • Kenmotsu, Hirotsugu;
    • Koyama, Takafumi;
    • Maeda, Takahiro;
    • Morita, Sachi;
    • Sakai, Daisuke;
    • Kohsaka, Shinji;
    • Tsuchihara, Katsuya;
    • Saigusa, Yusuke;
    • Yoshino, Takayuki
    Publication type:
    Article
    28
    29
    30
    31

    Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3646, doi. 10.1111/cas.15504
    By:
    • Imai, Mitsuho;
    • Nakamura, Yoshiaki;
    • Sunami, Kuniko;
    • Kage, Hidenori;
    • Komine, Keigo;
    • Koyama, Takafumi;
    • Amano, Toraji;
    • Ennishi, Daisuke;
    • Kanai, Masashi;
    • Kenmotsu, Hirotsugu;
    • Maeda, Takahiro;
    • Morita, Sachi;
    • Sakai, Daisuke;
    • Bando, Hideaki;
    • Makiyama, Akitaka;
    • Suzuki, Tatsuya;
    • Hirata, Makoto;
    • Kohsaka, Shinji;
    • Tsuchihara, Katsuya;
    • Naito, Yoichi
    Publication type:
    Article
    32
    33
    34

    Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3877, doi. 10.1111/cas.15479
    By:
    • Nishio, Shin;
    • Yonemori, Kan;
    • Usami, Tomoka;
    • Minobe, Shinichiro;
    • Yunokawa, Mayu;
    • Iwata, Takashi;
    • Okamoto, Aikou;
    • Aoki, Yoichi;
    • Itamochi, Hiroaki;
    • Takekuma, Munetaka;
    • Harano, Kenichi;
    • Yamamoto, Keiko;
    • Maruko, Takeshi;
    • Ugai, Hiroyuki;
    • Tekin, Cumhur;
    • Colombo, Nicoletta;
    • Fujiwara, Keiichi;
    • Hasegawa, Kosei;
    • Ushijima, Kimio
    Publication type:
    Article
    35
    36

    Issue Information.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3639, doi. 10.1111/cas.14963
    Publication type:
    Article